Skip to main content

Table 3 Univariate and multivariable competing risk model regression analyses of CSS in oral cavity squamous cell carcinoma

From: Survival analysis of age-related oral squamous cell carcinoma: a population study based on SEER

Clinicopathological variables

Univariate analysis

Multivariate analysis

SHR (95%CI)

P

SHR (95%CI)

P

Age at diagnosis

 18–39

Reference

 

Reference

 

 40–49

1.04 (0.91–1.18)

0.590

0.98 (0.86–1.12)

0.800

 50–59

1.17 (1.04–1.32)

0.011

1.06 (0.94–1.20)

0.360

 60–69

1.37 (1.21–1.55)

< 0.001

1.21 (1.07–1.38)

0.002

 70 + 

2.05 (1.82–2.32)

< 0.001

1.85 (1.63–2.10)

< 0.001

Sex

 Female

Reference

 

Reference

 

 Male

0.84 (0.81–0.88)

< 0.001

0.85 (0.81–0.89)

< 0.001

Marital status

 Married

Reference

 

Reference

 

 Unmarried

1.71 (1.65–1.78)

< 0.001

1.33 (1.27–1.38)

< 0.001

Race

 White

Reference

 

Reference

 

 Black

1.86 (1.76–1.97)

 < 0.001

1.29 (1.20–1.38)

< 0.001

 Asian or Pacific Islander

1.08 (0.99–1.18)

0.072

1.18 (1.08–1.29)

< 0.001

 American Indian/Alaska Native

1.11 (0.86–1.42)

0.430

1.06 (0.82–1.36)

0.650

Location

 Floor of mouth

Reference

 

Reference

 

 Other mouth

0.64 (0.60–0.69)

< 0.001

0.60 (0.55–0.64)

< 0.001

 Tongue

0.72 (0.68–0.77)

< 0.001

0.76 (0.71–0.82)

< 0.001

Size

 < 1

Reference

 

Reference

 

 < 2

1.65 (1.45–1.88)

< 0.001

1.51 (1.33–1.72)

< 0.001

 < 3

2.49 (2.20–2.82)

< 0.001

1.83 (1.57–2.12)

< 0.001

 < 4

3.21 (2.84–3.64)

< 0.001

2.11 (1.80–2.47)

< 0.001

 < 5

4.56 (4.02–5.17)

< 0.001

2.59 (2.20–3.05)

< 0.001

 ≥ 5

7.37 (6.51–8.34)

< 0.001

3.39 (2.87–4.00)

< 0.001

 Unknown

4.46 (3.94–5.06)

< 0.001

2.73 (2.29–3.25)

< 0.001

Treatment

 No/unknown

Reference

 

Reference

 

 Surgery

0.163 (0.15–0.18)

< 0.001

0.33 (0.29–0.37)

< 0.001

 Radiation

0.441 (0.40–0.49)

< 0.001

0.53 (0.47–0.59)

< 0.001

 Chemotherapy + XRT

0.28 (0.26–0.30)

< 0.001

0.33 (0.30–0.36)

< 0.001

 Surgery + XRT

0.23 (0.21–0.25)

< 0.001

0.35 (0.32–0.39)

< 0.001

 Triple therapy

0.23 (0.21–0.25)

< 0.001

0.34 (0.31–0.38)

< 0.001

 Others

0.74 (0.66–0.83)

< 0.001

0.65 (0.57–0.75)

< 0.001

Grade

 Well-differentiated

Reference

 

Reference

 

 Moderately differentiated

1.28 (1.21–1.36)

< 0.001

1.08 (1.01–1.16)

0.023

 Poorly differentiated

1.05 (0.99–1.12)

0.130

0.86 (0.80–0.93)

< 0.001

 Undifferentiated

0.87 (0.69–1.11)

0.260

0.69 (0.54–0.88)

0.003

T classification

 T1

Reference

 

Reference

 

 T2

1.80 (1.70–1.92)

< 0.001

1.17 (1.06–1.30)

0.002

 T3

3.09 (2.89–3.30)

< 0.001

1.29 (1.15–1.45)

< 0.001

 T4

4.48 (4.23–4.75)

< 0.001

1.94 (1.74–2.16)

< 0.001

 Unknown

2.18 (2.01–2.36)

< 0.001

0.85 (0.73–0.98)

0.025

N classification

 N0

Reference

 

Reference

 

 N1

1.52 (1.43–1.60)

< 0.001

1.48 (1.39–1.58)

< 0.001

 N2

1.63 (1.55–1.70)

< 0.001

1.56 (1.47–1.65)

< 0.001

 N3

2.34 (2.14–2.57)

< 0.001

2.06 (1.84–2.31)

< 0.001

 Unknown

2.87 (2.46–3.35)

< 0.001

1.50 (1.26–1.79)

< 0.001

M classification

 M0

Reference

 

Reference

 

 M1

4.39 (4.05–4.76)

< 0.001

2.62 (2.36–2.90)

< 0.001

 Unknown

2.60 (2.11–3.22)

< 0.001

1.47 (1.12–1.93)

0.006